Kraj: Malezja
Język: angielski
Źródło: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
HUMAN FIBRINOGEN; APROTININ; THROMBIN; CALCIUM CHLORIDE
BAXTER HEALTHCARE (MALAYSIA) SDN. BHD.
HUMAN FIBRINOGEN; APROTININ; THROMBIN; CALCIUM CHLORIDE
2ml mL; 4ml mL; 10ml mL
Takeda Manufacturing Austria AG
BAXTER 1. NAME OF THE MEDICINAL PRODUCT ARTISS Solutions for Sealant Deep frozen 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Component 1: Sealer Protein Solution Human Fibrinogen 91 mg 1 /ml (as clottable protein) produced from the plasma of human donors Aprotinin (synthetic) 3000 KIU 3 /ml Component 2: Thrombin Solution Human Thrombin 4 IU 3 /ml produced from the plasma of human donors Calcium Chloride 40 mol/ml 1 prefilled double chamber syringe which contains Sealer Protein Solution (with Aprotinin), deep frozen 1 ml, 2 ml, 5 ml, in one chamber and Thrombin Solution (with Calcium Chloride), deep frozen 1 ml, 2 ml, 5 ml, in the other chamber results in 2 ml, 4 ml, 10 ml, total volume of product ready for use. After mixing 1 ml 2 ml 4 ml 10 ml Component 1: Sealer protein solution Human Fibrinogen (as clottable protein) Aprotinin (synthetic) 45.5 mg 1,500 KIU 91 mg 3,000 KIU 182 mg 6,000 KIU 455 mg 15,000 KIU Component 2: Thrombin Solution Human Thrombin Calcium Chloride 2 IU 20 mol 4 IU 40 mol 8 IU 80 mol 20 IU 200 mol ARTISS contains Human Factor XIII co-purified with Human Fibrinogen in a range of 0.6 – 5 IU/ml. For the full list of excipients, see section 6.1. 1 Contained in a total protein concentration of 96 - 125 mg/ml 2 1 EPU (European Pharmacopoeia Unit) corresponds to 1800 KIU (Kallidinogenase Inactivator Unit) 3 Thrombin activity is calculated using the current WHO International Standard for Thrombin. 3. PHARMACEUTICAL FORM Solutions for Sealant Deep frozen Colourless to pale yellow and clear to slightly turbid solutions. Component 1, Sealer Protein Solution: pH 6.5 – 8.0 Component 2, Thrombin Solution: pH 6.0 – 8.0 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ARTISS is indicated as a tissue glue to adhere/seal subcutaneous tissue in plastic, reconstructive and burn surgery, as a replacement or an adjunct to sutures or staples (see 5.1). ARTISS is not indicated for hemostasis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ARTISS is intended for hospital use only. The use of Przeczytaj cały dokument